TrialThe Clinical journal of pain2017

Safety and Efficacy of a Topical Sodium Channel Inhibitor (TV-45070) in Patients With Postherpetic Neuralgia (PHN): A Randomized, Controlled, Proof-of-Concept, Crossover Study, With a Subgroup Analysis of the Nav1.7 R1150W Genotype.

Nicola Price et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.